Forte Biosciences, Inc. — Form D
Forte Biosciences, Inc. of Torrance, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-15. The offering totals $20.0M, of which $19.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-06-15
- Form: D
- Accession: 0001761323-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $19.4M
- Remaining: $565K
- Investors: 19
- Date of first sale: 2020-06-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-369003
Issuer
- Name: Forte Biosciences, Inc.
- CIK: 0001761323
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1124 W. Carson Street, Torrance, CA, 90502
- Phone: 310-618-6994
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Paul A Wagner, Ph.D. | Director | Torrance, CA |
| Antony A Riley | Executive Officer | Torrance, CA |
| Paul A Wagner, Ph.D. | Executive Officer | Torrance, CA |
| Lawrence Eichenfield | Director | Dallas, TX |
| Paul Wagner | Director | Spokane, WA |
| Paul Wagner | Executive Officer | Spokane, WA |
| Tuan Huynh | Director | Laguna Hills, CA |
Other filings by this issuer (1)
More